Adalta Ltd. has released a press release.
BZDS1901 special access scheme launch in China
Earlier from Adalta
- EW-001 IIT study overall survival update
- 2 year survival milestone for EW-001 patient
- Oktopi AI collaboration for research efficiency
- Second BZDS1901 milestone paid